Abbott Laboratories (NYSE:ABT)

clinical trials

Merrill Lynch 4 Top Pharmaceutical Dividend Stocks To Own For 2016

Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the need and demand for pharmaceuticals will only continue. This is especially ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott, BioMarin, CBS, Cisco, GameStop, Petrobras, Sirius XM, SunPower, Yelp and More

Stocks were indicated slightly lower on Friday the 13th, but that is also after a sharp drop on Thursday. Sell-offs create panic, but they also create opportunity. So far, the ...
Read Full Story »
Medicine pills

4 Top Merrill Lynch Dividend-Paying Pharmaceutical Stocks to Buy Now

If any proverbial baby has been tossed out with the stock market bath water this year, it’s been the large cap pharmaceuticals. A combination of hot political rhetoric, opportunistic event-driven ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Adobe, FireEye, Lululemon, Nu Skin, Rio Tinto, Tesla, BHP Billiton and Many More

Stocks traded sharply higher Wednesday morning. Yet again, investors are buying value and looking for bargains, now that the stock market pulled back so much before this last rally. 24/7 ...
Read Full Story »
Medtronic device

2 Deutsche Bank Health Care Focus Stocks Have Big Upside Potential

If any arena has taken a beating for no real reason, it is all of the subsectors of the medical arena. Whether it is drugs or devices, populist political chatter ...
Read Full Story »
White House South Lawn, Blue Sky, Washington, DC, USA

Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter

When presidential candidate Hillary Clinton stirred the market this week with a campaign announcement on a proposed crackdown on drug pricing, and more regulations on the pharmaceutical industry, many of ...
Read Full Story »
Pfizer logo

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

One of the metrics that analysts and strategists follow closely is the three-month earnings revision ratio. While analysts continue to make more downward to upward revisions, the number is improving. ...
Read Full Story »

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and we have taken a look at companies in a variety of sectors that will be posting results next week. The health ...
Read Full Story »
generic drugs

Can Perrigo Get More From Mylan?

Just before lunchtime on Wednesday, generic drug maker Mylan N.V. (NASDAQ: MYL) proposed to acquire rival Perrigo Co. PLC (NYSE: PRGO) for $205 per share in cash and stock. Perrigo, ...
Read Full Story »
generic drugs

Does the Mylan Secondary Make Its Stock Cheap?

Mylan N.V. (NASDAQ: MYL) announced that it would have a 35 million share secondary offering. At Tuesday's closing price of $59.35, the offering would be valued at $2.08 billion. Total assets owned by ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Cameron, Dollar General, Genworth, Groupon, SunPower, Visa, Yahoo and More

Stocks were hit hard early Friday before the preliminary fourth-quarter gross domestic product reading. What has been observed over and over is that investors have bought the dips and pullbacks ...
Read Full Story »

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

Although it is a subject many investors would like to avoid, for obvious reasons, the growth in the number of sexually transmitted diseases (or STDs, as they are called) is ...
Read Full Story »

Jefferies Has 5 Stocks to Buy With Big Catalysts This Week

With earnings season in full force this week, the presentation of quarterly numbers will likely drive the direction of many stocks. Despite a huge turnaround by the markets on Friday, ...
Read Full Story »

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late. The move is also ...
Read Full Story »
Abbott Laboratories Logo

Abbott, Mylan Join Forces to Dodge U.S. Taxes

Add one more to the litany of pharmaceutical company mergers that are being made to avoid U.S. taxes. Abbott Laboratories (NYSE: ABT) has agreed to sell its non-U.S. generic drug business ...
Read Full Story »